Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 276,135 | 267,562 | 262,903 | 276,279 | 273,163 |
| Cost of Goods | 166,927 | 168,158 | 161,669 | 168,393 | 167,427 |
| Gross Profit | 109,208 | 99,404 | 101,234 | 107,886 | 105,736 |
| Operating Expenses | 21,015 | 15,428 | 19,076 | 20,362 | 21,567 |
| Operating Income | 89,120 | 84,134 | 82,827 | 87,917 | 84,596 |
| Interest Expense | 2,561 | 2,794 | 2,363 | 2,483 | 2,302 |
| Pre-tax Income | 86,559 | 81,340 | 80,464 | 85,434 | 82,294 |
| Income Tax | 19,909 | 17,244 | 19,311 | 20,718 | 20,490 |
| Net Income Continuous | 66,650 | 64,096 | 61,153 | 64,716 | 61,804 |
| Minority Interests | 153 | 362 | 89 | -8 | -91 |
| Net Income | $66,497 | $63,734 | $61,064 | $64,724 | $61,895 |
| EPS Basic Total Ops | 1.51 | 1.43 | 1.36 | 1.43 | 1.36 |
| EPS Basic Continuous Ops | 1.51 | 1.44 | 1.36 | 1.43 | 1.36 |
| EPS Diluted Total Ops | 1.50 | 1.42 | 1.35 | 1.42 | 1.35 |
| EPS Diluted Continuous Ops | 1.50 | 1.43 | 1.35 | 1.42 | 1.35 |
| EBITDA(a) | $95,965 | $90,452 | $89,460 | $94,286 | $91,709 |